BioXcel Seeks OK For $9.8M Deal With Investors
Artificial intelligence-powered pharmaceutical group BioXcel has asked a Delaware bankruptcy judge to sign off on a $9.75 million settlement between the debtor and plaintiffs in a securities class action against it,...To view the full article, register now.
Already a subscriber? Click here to view full article